Toshiba Corporation has announced that it has licensed key patents on DNA chips and DNA detection and analysis to Antara BioSciences Inc. of the United States.
The license covers the application of Toshiba-developed and patented DNA chips and electrochemical DNA analysis system to in vitro diagnosis of disease in humans within the United States.
Antara plans to develop DNA chips and diagnostic systems based on the licensed patents and guide the products through the approval procedures of the Food and Drug Administration (FDA).
Toshiba established the Business Development Office at its Corporate Research & Development Center in Kawasaki, Japan in 2001, to investigate promising new business areas.
This approach bore fruit in DNA-based diagnostics: Toshiba developed the Genelyzer™ portable, automated DNA detection system in 2003, and, in 2004, a DNA chip that was small, sensitive, and based on Complementary Metal Oxide Semiconductor (CMOS) technology, the mainstream IC technology.